U.S. Department Of Defense Issued Contract For COVID Research 3 Months Before COVID Was Known To Exist
April 6, 2023
Study Suggests Branched-Chain Amino Acid Supplementation May Delay Cognitive Decline
April 13, 2023

Pfizer Hid Data On Waning Immunity As Millions Queued To Get Vaccinated


“New regulatory filings show Pfizer had evidence, early into the COVID-19 vaccination campaign, that its vaccine’s efficacy waned, but waited months before alerting the public.”
[Source: substack.com]

[Image source: Wikimedia]


As with much of Pfizer’s conduct during the COVID-19 pandemic, we can only conclude that the delay in acknowledging the waning of its vaccine’s efficacy was fueled by a desire to maximize profits. Notably, therefore, with sales of $37.8 billion for the vaccine alone during 2022, the company’s total revenue for that year reached a staggering $100 billion. This is despite Pfizer CEO Albert Bourla having previously claimed that the company would sell the vaccine for just a “marginal profit.”

Other aspects of Pfizer’s behavior in relation to its COVID-19 vaccine development are even more disturbing. For example, a researcher involved in the clinical trial that was carried out to obtain ‘emergency use authorization’ for the shot has revealed that some of the study data claimed to have been obtained from the tests were falsified. In an alarming investigation that has been largely ignored by most of the mainstream media, the British Medical Journal reports that staff conducting quality control checks for the trial were ‘overwhelmed’ by the volume of problems they were finding. Staff raising these issues with their managers were apparently targeted and even fired. Such allegations seriously undermine the claim that the mRNA technology used in Pfizer’s COVID-19 vaccine has been scientifically ‘proven’ to be safe.

To read how the Pfizer vaccine has been shown to be more likely to cause serious adverse events than it is to prevent hospitalization with COVID-19, see this article on our website.